Introducing Dr. Beatriz Moiraghi! She has worked as a hematologist for 25 years in Argentina and has been a Max partner physician since 2002. Learn more about her below.
Describe a typical work week:
On a typical workday, I arrive at the hospital early, at 7 a.m. I not only see patients from the Max program but also more than 250 patients with chronic myeloid leukemia.
How many patients are you treating in the program?
In the The Max Foundation program, I see approximately ten patients.
Is there a patient experience that stayed with you?
I have many stories about my patients, particularly when they receive their molecular test results and I can explain that everything is more than fine with the disease. I always emphasize adherence to the daily medication without missing any doses. Another memory is the look of surprise on their faces, relief at receiving treatment and hope for the future.
When you’re not working, what do you like to do for fun?
I watch movies and TV series, and I read all kinds of novels. What I enjoy most is traveling, discovering new places, and meeting local people.
What languages do you speak?
I speak Spanish.
What is your favorite food?
I like to eat salmon.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
By Dr. Mipsang Lama Partner Physician at Patan Hospital in Nepal When Treatment Feels Like a Miracle Paroxysmal nocturnal hemoglobinuria (PNH) is a rare and devastating blood disorder. In many high-income countries, it is a condition with established treatment pathways. But in Nepal, for years, it was something we could diagnose, yet not truly treat…..
We’re often reminded of why we put an effort in supporting people facing cancer – whether it comes through a patient story or through an organization’s investment in our work. This week, we humbly received another reminder: on Friday, May 22, the International Chronic Myeloid Leukemia (CML) Foundation awarded our CEO Pat Garcia-Gonzalez with the inaugural ERSAP (Emerging Region Support and Partnership) Prize. The iCMLf Directors and Scientific Advisors selected Pat because of her continued commitment, and The Max Foundation’s aim, to help people face cancer with dignity and hope.
All of us at The Max Foundation are wholly committed to maximizing every opportunity to collaborate and build new partnerships on behalf of the patients we serve in low resource settings. We are excited to move onward to a new chapter with innovative opportunities to expand our impact. We hope you will see a place for yourself to join us in this effort to close the cancer divide!
